Pages that link to "Q26751326"
Jump to navigation
Jump to search
The following pages link to Autophagy: a new target for nonalcoholic fatty liver disease therapy (Q26751326):
Displayed 22 items.
- The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy (Q38714006) (← links)
- Diet regulates liver autophagy differentially in murine acute Trypanosoma cruzi infection (Q39185798) (← links)
- Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century (Q39333577) (← links)
- IMM-H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high-fat diet (Q41627727) (← links)
- Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease. (Q50194612) (← links)
- Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux. (Q52728091) (← links)
- Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver. (Q53688960) (← links)
- Chlorogenic acid alleviates autophagy and insulin resistance by suppressing JNK pathway in a rat model of nonalcoholic fatty liver disease. (Q54976944) (← links)
- Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD. (Q55353848) (← links)
- Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma (Q58693431) (← links)
- Oleuropein Induces AMPK-Dependent Autophagy in NAFLD Mice, Regardless of the Gender (Q60907786) (← links)
- SVIP alleviates CCl-induced liver fibrosis via activating autophagy and protecting hepatocytes (Q61443693) (← links)
- Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma (Q64063998) (← links)
- Targeting autophagy in cancer (Q88406511) (← links)
- Targeting autophagy in obesity: from pathophysiology to management (Q88447728) (← links)
- Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management (Q89126294) (← links)
- Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis (Q90047443) (← links)
- sMutations in the V-ATPase assembly factor VMA21 cause a congenital disorder of glycosylation with autophagic liver disease (Q90126384) (← links)
- Role of spleen tyrosine kinase in liver diseases (Q90607835) (← links)
- Resveratrol, an activator of SIRT1, improves ER stress by increasing clusterin expression in HepG2 cells (Q92648492) (← links)
- Effect of Betaine Supplementation on Liver Tissue and Ultrastructural Changes in Methionine-Choline-Deficient Diet-Induced NAFLD (Q98385703) (← links)
- Sophoricoside Ameliorates Cardiac Hypertrophy by activating AMPK/mTORC1-mediated autophagy (Q99611339) (← links)